# C_2008135EN.01003801.xml

| 3.6.2008 | EN | Official Journal of the European Union | C 135/38 |
| --- | --- | --- | --- |

3.6.2008

EN

Official Journal of the European Union

C 135/38

---

Prior notification of a concentration

(Case COMP/M.5190 — Nordic Capital/ConvaTec)

(Text with EEA relevance)

(2008/C 135/07)

| 1. | On 27 May 2008, the Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1) by which the undertaking Nordic Capital (‘Nordic Capital’, Jersey) acquires within the meaning of Article 3(1)(b) of the Council Regulation control of the whole of the undertaking ConvaTec (‘ConvaTec’, USA), a wholly owned business unit of Bristol-Myers Squibb Co. (‘BMS’, USA), by way of purchase of shares and assets. |
| --- | --- |

1.

On 27 May 2008, the Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1) by which the undertaking Nordic Capital (‘Nordic Capital’, Jersey) acquires within the meaning of Article 3(1)(b) of the Council Regulation control of the whole of the undertaking ConvaTec (‘ConvaTec’, USA), a wholly owned business unit of Bristol-Myers Squibb Co. (‘BMS’, USA), by way of purchase of shares and assets.

1

| 2. | The business activities of the undertakings concerned are:






  — | for Nordic Capital: private equity company, |
| --- | --- | --- |

2.

The business activities of the undertakings concerned are:

—

for Nordic Capital: private equity company,

| — | for ConvaTec: manufacture, marketing and sale of advanced wound care, ostomy and faecal incontinence products. |
| --- | --- |

—

for ConvaTec: manufacture, marketing and sale of advanced wound care, ostomy and faecal incontinence products.

| 3. | On preliminary examination, the Commission finds that the notified transaction could fall within the scope of Regulation (EC) No 139/2004. However, the final decision on this point is reserved. |
| --- | --- |

3.

On preliminary examination, the Commission finds that the notified transaction could fall within the scope of Regulation (EC) No 139/2004. However, the final decision on this point is reserved.

| 4. | The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.
  Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax ((32-2) 296 43 01 or 296 72 44) or by post, under reference number COMP/M.5190 — Nordic Capital/ConvaTec, to the following address:





  European Commission |
| --- | --- |
| Directorate-General for Competition |
| Merger Registry |
| J-70 |
| B-1049 Bruxelles/Brussel |

4.

The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.

Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax ((32-2) 296 43 01 or 296 72 44) or by post, under reference number COMP/M.5190 — Nordic Capital/ConvaTec, to the following address:

European Commission

Directorate-General for Competition

Merger Registry

J-70

B-1049 Bruxelles/Brussel

---

(1)  OJ L 24, 29.1.2004, p. 1.

1

---